Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7alpha-hydroxylase and 27-hydroxylase activities in rat liver.

The Smith-Lemli-Opitz syndrome (SLOS) is a congenital birth defect syndrome caused by a deficiency of 3beta-hydroxysterol Delta(7)-reductase, the final enzyme in the cholesterol biosynthetic pathway. The patients have reduced plasma and tissue cholesterol concentrations with the accumulation of 7-dehydrocholesterol and 8-dehydrocholesterol. Bile acid synthesis is reduced and unnatural cholenoic and cholestenoic acids have been identified in some SLOS patients. To explore the mechanism of the abnormal bile acid production, the activities of key enzymes in classic and alternative bile acid biosynthetic pathways (microsomal cholesterol 7alpha-hydroxylase and mitochondrial sterol 27-hydroxylase) were measured in liver biopsy specimens from two mildly affected SLOS patients. The effects of 7- and 8-dehydrocholesterols on these two enzyme activities were studied by using liver from SLOS model rats that were treated with the Delta(7)-reductase inhibitor (BM15.766) for 4 months and were comparable with more severe SLOS phenotype in plasma and hepatic sterol compositions. In the SLOS patients, cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase were not defective. In BM15.766-treated rats, both enzyme activities were lower than those in control rats and they were competitively inhibited by 7- and 8-dehydrocholesterols. Rat microsomal cholesterol 7alpha-hydroxylase did not transform 7-dehydrocholesterol or 8-dehydrocholesterol into 7alpha-hydroxylated sterols. In contrast, rat mitochondrial sterol 27-hydroxylase catalyzed 27-hydroxylation of 7- and 8-dehydrocholesterols, which were partially converted to 3beta-hydroxycholestadienoic acids. Addition of microsomes to the mitochondrial 27-hydroxylase assay mixture reduced 27-hydroxydehydrocholesterol concentrations, which suggested that 27-hydroxydehydrocholesterols were further metabolized by microsomal enzymes. These results suggest that reduced normal bile acid production is characteristic of severe SLOS phenotype and is caused not only by depletion of hepatic cholesterol but also by competitive inhibition of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase activities by accumulated 7- and 8-dehydrocholesterols. Unnatural bile acids are synthesized mainly by the alternative pathway via mitochondrial sterol 27-hydroxylase in SLOS.

[1]  R. Hennekam,et al.  The Smith-Lemli-Opitz syndrome , 2000, Journal of medical genetics.

[2]  P. Vreken,et al.  Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene. , 1998, American journal of human genetics.

[3]  G. Utermann,et al.  Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  R. Servatius,et al.  Relationship between abnormal cholesterol synthesis and retarded learning in rats. , 1998, Metabolism: clinical and experimental.

[5]  D. S. Lin,et al.  Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome. , 1998, American journal of human genetics.

[6]  J. Chiang Regulation of bile acid synthesis. , 1998, Frontiers in bioscience : a journal and virtual library.

[7]  A. Honda,et al.  Synthesis of [3α-3H]7-dehydrocholesterol via stable tritiated 4-phenyl-1,2,4-triazoline-3,5-dione derivative , 1997, Steroids.

[8]  M. Siimes,et al.  Apoprotein E phenotype determines serum cholesterol in infants during both high-cholesterol breast feeding and low-cholesterol formula feeding. , 1997, Journal of lipid research.

[9]  A. Honda,et al.  Effect of YM 9429, a potent teratogen, on cholesterol biosynthesis in cultured cells and rat liver microsomes , 1996, Steroids.

[10]  A. Honda,et al.  Regulation of the last two enzymatic reactions in cholesterol biosynthesis in rats: Effects of BM 15.766, cholesterol, cholic acid, lovastatin, and their combinations , 1996, Hepatology.

[11]  W. K. Wilson,et al.  Analysis of unsaturated C27 sterols by nuclear magnetic resonance spectroscopy. , 1996, Journal of lipid research.

[12]  A. Honda,et al.  Markedly inhibited 7-dehydrocholesterol-delta 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes. , 1995, The Journal of clinical investigation.

[13]  A. Honda,et al.  Defective conversion of 7-dehydrocholesterol to cholesterol in cultured skin fibroblasts from Smith-Lemli-Opitz syndrome homozygotes. , 1995, Journal of lipid research.

[14]  G. Tint,et al.  Identification of 8-dehydrocholesterol (cholesta-5,8-dien-3 beta-ol) in patients with Smith-Lemli-Opitz syndrome. , 1995, Journal of lipid research.

[15]  J. Evans,et al.  Abnormal bile acids in the Smith-Lemli-Opitz syndrome. , 1994, American journal of medical genetics.

[16]  T. Buie,et al.  Abnormal cholesterol metabolism in the Smith-Lemli-Opitz syndrome: report of clinical and biochemical findings in four patients and treatment in one patient. , 1994, American journal of medical genetics.

[17]  G Salen,et al.  Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. , 1994, The New England journal of medicine.

[18]  G. Tint,et al.  Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome , 1993, The Lancet.

[19]  J. Sjövall,et al.  Synthesis of potential C27-intermediates in bile acid biosynthesis and their deuterium-labeled analogs , 1993, Steroids.

[20]  J. Clayton-Smith Syndromes of the Head and Neck , 1993 .

[21]  G. Ness,et al.  Differing effects of cholesterol and taurocholate on steady state hepatic HMG-CoA reductase and cholesterol 7 alpha-hydroxylase activities and mRNA levels in the rat. , 1992, Journal of lipid research.

[22]  D. Russell,et al.  Bile acid biosynthesis. , 1992, Biochemistry.

[23]  M. Axelson Occurrence of isomeric dehydrocholesterols in human plasma. , 1991, Journal of lipid research.

[24]  D. Russell,et al.  Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis. , 1991, The Journal of biological chemistry.

[25]  N. Shigematsu,et al.  Simultaneous assay of the activities of two key enzymes in cholesterol metabolism by gas chromatography-mass spectrometry. , 1991, Journal of chromatography.

[26]  G. Ness,et al.  Regulation of cholesterol 7 alpha-hydroxylase by hepatic 7 alpha-hydroxylated bile acid flux and newly synthesized cholesterol supply. , 1991, The Journal of biological chemistry.

[27]  P. Hylemon,et al.  Regulation of bile acid synthesis. V. Inhibition of conversion of 7-dehydrocholesterol to cholesterol is associated with down-regulation of cholesterol 7 alpha-hydroxylase activity and inhibition of bile acid synthesis. , 1990, Journal of lipid research.

[28]  W. K. Wilson,et al.  Inhibitors of sterol synthesis. Chemical synthesis, structure, and biological activities of (25R)-3 beta,26-dihydroxy-5 alpha-cholest-8(14)-en-15-one, a metabolite of 3 beta-hydroxy-5 alpha-cholest-8(14)-en-15-one. , 1989, Journal of lipid research.

[29]  N. Tanaka,et al.  Similarity of unusual bile acids in human umbilical cord blood and amniotic fluid from newborns and in sera and urine from adult patients with cholestatic liver diseases. , 1988, Journal of lipid research.

[30]  F. Carubbi,et al.  Bile acid synthesis. Metabolism of 3 beta-hydroxy-5-cholenoic acid to chenodeoxycholic acid. , 1986, The Journal of biological chemistry.

[31]  K. Taysi,et al.  Possible abnormalities of steroid secretion in children with Smith-Lemli-Opitz syndrome and their parents , 1985, Steroids.

[32]  A. Batta,et al.  Regulation of bile acid synthesis. Measurement of cholesterol 7 alpha-hydroxylase activity in rat liver microsomal preparations in the absence of endogenous cholesterol. , 1981, Journal of lipid research.

[33]  G. Gibbons,et al.  The formation of cholest-5-ene-3 ,26-diol as an intermediate in the conversion of cholesterol into bile acids by liver mitochondria. , 1972, The Biochemical journal.

[34]  I. Bekersky,et al.  Biochemical site of regulation of bile acid biosynthesis in the rat. , 1970, Journal of lipid research.

[35]  N. Javitt,et al.  Effect of sodium taurolithocholate on bile flow and bile acid exeretion. , 1968, The Journal of clinical investigation.

[36]  K. Einarsson,et al.  Effect of Biliary Drainage on Individual Reactions in the Conversion of Cholesterol to Taurocholic Acid , 1967 .

[37]  J. Opitz,et al.  A NEWLY RECOGNIZED SYNDROME OF MULTIPLE CONGENITAL ANOMALIES. , 1964, The Journal of pediatrics.

[38]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[39]  M. Seller,et al.  Markedly increased tissue concentrations of 7-dehydrocholesterol combined with low levels of cholesterol are characteristic of the Smith-Lemli-Opitz syndrome. , 1995, Journal of lipid research.

[40]  J. Opitz,et al.  Smith-Lemli-Opitz syndrome-type II: multiple congenital anomalies with male pseudohermaphroditism and frequent early lethality. , 1987, American journal of medical genetics.